肿瘤相关巨噬细胞—肝癌细胞三维共培养体系中分泌蛋白的差异及CXCL2在肝癌转移中的作用
本文选题:肝细胞癌 + 肿瘤微环境 ; 参考:《广西医科大学》2017年博士论文
【摘要】:第一部分肿瘤相关巨噬细胞的诱导、鉴定及其对肝癌细胞的影响肝癌是经典的炎症相关性肿瘤,肝癌细胞所在微环境内浸润着大量肿瘤相关巨噬细胞,并以M2型肿瘤相关巨噬细胞为主。本部分研究旨在通过体外诱导获得不同活化状态巨噬细胞并明确其对肝癌细胞生物学行为的影响。我们首先通过人单核白血病细胞THP-1经佛波酯诱导为未分化巨噬细胞(UM0),再分别经脂多糖,白介素4和13诱导获得经典活化的巨噬细胞M1及选择性激活的巨噬细胞M2;然后通过形态学、荧光定量PCR和ELISA对其表型进行鉴定;最后从增殖、迁移及侵袭实验探索不同活化状态巨噬细胞条件培养基(conditioned medium,CM)对肝癌细胞生物学行为的影响,并检测了肝癌细胞中上皮-间质化转换(EMT)标志物的变化。结果显示:(1)与UM0相比,M1呈长梭形或多边形,TNF-α和CCL3 m RNA的表达量及IL-12的分泌均明显升高;M2伪足细长而杂乱、呈抱团式生长,AMAC-1、CCL22和Arg-1 m RNA的表达量及IL-10的分泌均显著增加。该检测结果与文献报道的结果一致,说明已成功诱导获得不同活化状态的巨噬细胞;(2)生物学功能实验显示经M2CM处理后的肝癌细胞与对照组相比,其增殖、迁移和侵袭能力均显著增强,而M1CM处理的肝癌细胞则无明显变化,说明M2型肿瘤相关巨噬细胞能显著促进肝癌细胞恶性变;(3)经M2CM处理后的肝癌细胞上皮标志物E-cadherin的表达明显下降,伴随间质细胞标志物N-cadherin、Vimentin和α-SMA显著上升,经M1CM处理的肝癌细胞各标志物的表达量均无明显变化,说明仅有经M2CM处理后的肝癌细胞发生了EMT。第二部分肿瘤相关巨噬细胞和肝癌细胞三维共培养体系中分泌蛋白的差异体内状态的肿瘤细胞生存于立体、复杂而开放的微环境中,分泌蛋白是该微环境中肿瘤细胞与TAMs间相互作用的重要桥梁。在本部分研究中,我们利用低熔点琼脂糖作为支架建立肿瘤相关巨噬细胞与肝癌细胞的三维立体共培养体系,通过i TRAQ标记为基础的定量蛋白质组学技术对三维培养体系中的分泌蛋白进行比较分析和筛选,并应用Western-Blot对部分差异蛋白的鉴定结果进行验证。结果显示:(1)不同三维立体培养体系中的条件培养基经i TRAQ标记、质谱分析及数据库搜索,一共鉴定到了26677条肽段及1640个蛋白(99%可信度)。将鉴定到的蛋白按比值1.3定义为上调,比值0.7定义为下调的准则进行筛选,发现在与M2比较时,有333个分泌蛋白差异性表达在M2+SMMC7721共培养体系;在与SMMC7721比较时,有357个分泌蛋白差异性表达在M2+SMMC7721共培养体系;同时与M2、SMMC7721单一立体培养体系比较时,有159个分泌蛋白差异性表达在M2+SMMC7721共培养体系中,其中上调的差异性分泌蛋白为63个,下调的为96个。(2)Western-Blot的结果显示IL-8、IL-1β、HB-EGF和IGFBP3的变化趋势与质谱结果完全一致,而MMP3与CXCL2,虽发现其在M2CM中的表达高于SMMC7721CM与质谱结果相反,但两者均在共培养条件培养基中升高,该趋势与质谱结果一致。第三部分差异分泌蛋白CXCL2对肝癌细胞转移功能的影响及机制研究CXCL2在本研究中被发现是共培养条件培养基里明显上升的差异蛋白,且在M2CM中的表达高于SMMC7721CM,说明其主要源于M2。其对肝癌转移能力的影响及作用机制未明。本部分通过采用不同浓度的外源性重组CXCL2蛋白刺激肝癌细胞,以观察其对肝癌细胞迁移、侵袭、粘附等生物学行为的影响,并通过信号通路芯片及通路抑制剂等方法探索其可能的作用机制。结果显示:(1)CXCL2在10例肝癌患者肝癌组织中的表达比相应癌旁组织明显增高;(2)不同浓度CXCL2刺激均可显著增强肝癌细胞的迁移能力,1ng/m L刺激组的肝癌细胞侵袭能力明显增加,10ng/m L及100ng/m L CXCL2刺激组的肝癌细胞粘附能力显著降低;(3)中和共培养条件培养基中的CXCL2后其促进肝癌细胞迁移及侵袭能力的作用均明显下降;(4)通过特异性抑制剂SB225002抑制肝癌细胞表达的CXCR2后,CXCL2对肝癌细胞迁移、侵袭能力的促进作用及对其粘附能力的抑制作用均消失,说明CXCL2通过与其受体CXCR2相结合发挥作用;(5)CXCL2过表达后,通过信号通路芯片检测发现肝癌细胞中HSP27、PRAS40、bad,Chk1、Ik Bα(Ser32/36)的磷酸化水平均显著上调,Ik Bα(Total)也明显升高;Western blot的结果证实过表达CXCL2后肝癌细胞中p-Ik Bα的磷酸化水平明显增高,说明NF-k B通路在CXCL2过表达的肝癌细胞中被激活;(6)进一步通过NF-k B特异性抑制剂BAY117082阻断肝癌细胞的NF-k B通路,发现CXCL2促进肝癌细胞细胞迁移及侵袭的能力减弱。上述结果表明肿瘤相关巨噬细胞源性的CXCL2主要通过激活NF-k B信号通路促进肝癌细胞的迁移及侵袭。结论1.在体外成功诱导获得具有典型表型特征的不同活化状态巨噬细胞M1和M2;并发现M2条件培养基可促进肝癌细胞增殖、迁移及侵袭并发生EMT。2.成功应用低熔点琼脂糖建立肝癌细胞及M2型肿瘤相关巨噬细胞的三维立体共培养体系,通过i TRAQ标记的定量蛋白质组学技术建立了不同三维立体培养体系中的分泌蛋白表达谱,并从共培养体系中鉴定到了159个差异分泌蛋白。3.CXCL2是共培养体系中显著升高的蛋白,可促进肝癌细胞的迁移、侵袭能力,并抑制其粘附能力;其作用的发挥是通过与肝癌细胞表达的CXCR2受体结合,从而激活NF-k B信号通路进行。
[Abstract]:The first part is the induction of tumor related macrophages, identification and its effect on hepatoma cells. Liver cancer is a classic inflammatory tumor. A large number of tumor related macrophages are infiltrated by a large number of tumor related macrophages in the microring of the hepatoma cells, and M2 type tumor related macrophages are the main factors. This part of the study is aimed at obtaining different activation states through in vitro induction. Macrophage and its effect on the biological behavior of hepatoma cells. First of all, we induced undifferentiated macrophages (UM0) through human mononuclear cells THP-1 via phorbol ester, and then induced by lipopolysaccharide, interleukin 4 and 13 to obtain the classic activated macrophage M1 and selectively activated macrophage M2; and then through morphology, fluoro The phenotypes were identified by light quantitative PCR and ELISA. Finally, the effects of conditioned medium (CM) on the biological behavior of hepatoma cells were investigated from the proliferation, migration and invasion experiments, and the changes in the epithelial mesenchymal transition (EMT) markers in the hepatoma cells were detected. The results showed: (1) M, compared with UM0, M. 1 long spindle shape or polygon, the expression of TNF- alpha and CCL3 m RNA and the secretion of IL-12 were significantly increased; M2 pseudo foot was elongated and messy and cluttered. The expression of AMAC-1, CCL22 and Arg-1 m RNA and IL-10 secretion were all increased significantly. The results of this detection were consistent with the results reported in the literature, indicating that different activation states have been successfully induced. (2) (2) biological function experiments showed that the proliferation, migration and invasion of HCC cells treated by M2CM were significantly enhanced, while the M1CM treated hepatoma cells had no significant changes, indicating that the macrophages of type M2 tumor related macrophages could significantly promote the malignant transformation of liver cancer cells; (3) the epithelial cells of liver cancer treated by M2CM The expression of the marker E-cadherin was significantly decreased, with the interstitial cell marker N-cadherin, Vimentin and alpha -SMA significantly increased, and the expression of all the hepatoma cells treated by M1CM had no significant changes, indicating that the only M2CM treated hepatoma cells had a three dimensional co culture of the tumor related macrophages and hepatoma cells of the EMT. second parts. Tumor cells secreting proteins in the nutrient system exist in a three-dimensional, complex and open microenvironment. Secretory proteins are an important bridge between the interaction of tumor cells and TAMs in this microenvironment. In this part, we use low melting point agarose as a support to establish tumor related macrophages and hepatoma cells. A three-dimensional co culture system was used to compare and screen the secretory proteins in the three-dimensional culture system by quantitative proteomics based on I TRAQ markers. The results of identification of partial differential proteins were verified by Western-Blot. The results showed that: (1) the conditioned medium in different three-dimensional culture systems was treated with I TRAQ Markers, mass spectrometry and database search, 26677 peptides and 1640 proteins (99% reliability) were identified. The identified protein was up to up by ratio 1.3, and the ratio 0.7 was defined as down regulation. It was found that when compared with M2, 333 secretory proteins were expressed differentially in the M2+SMMC7721 co culture system; and in SMMC772 1 in comparison, 357 secretory proteins were expressed differently in the M2+SMMC7721 co culture system; at the same time, when compared with M2, SMMC7721 single stereoscopic culture system, 159 secretory proteins were expressed differently in the M2+SMMC7721 co culture system, among which 63 differential secretory proteins were up-regulated and 96 were downregulated. (2) the results of Western-Blot showed IL-8, I The changes in L-1 beta, HB-EGF and IGFBP3 were in full agreement with the mass spectrum, while MMP3 and CXCL2 showed that their expression in M2CM was higher than that of SMMC7721CM and mass spectrometry, but both of them were increased in co culture medium, and the trend was in accordance with the mass spectrum. Third differential secretory protein CXCL2 has a shadow on the metastasis function of liver cancer cells. In this study, CXCL2 was found to be a distinct rising protein in the co culture medium, and the expression in M2CM was higher than that of SMMC7721CM. It was mainly attributed to the effect of M2. on the metastasis ability of liver cancer and the mechanism of action was not clear. This part was used to stimulate liver cancer by using different concentrations of exogenous recombinant CXCL2 protein. Cell, to observe the effects of its biological behavior on the migration, invasion and adhesion of hepatoma cells, and to explore its possible mechanism by means of signal pathway chip and pathway inhibitor. The results showed: (1) the expression of CXCL2 in the liver cancer tissues of 10 patients with liver cancer was significantly higher than that of the corresponding para cancerous tissues; (2) different concentrations of CXCL2 stimulation could be used. Significantly enhanced migration of hepatoma cells, the invasion ability of hepatoma cells in 1ng/m L stimulation group increased significantly, and the adhesion ability of hepatoma cells in 10ng/m L and 100ng/m L CXCL2 stimulation group decreased significantly; (3) after neutralizing CXCL2 in the co culture medium, the effect of promoting the migration and invasion of hepatoma cells decreased obviously; (4) through special treatment. After the inhibition of the heterosexual inhibitor SB225002 to inhibit the expression of CXCR2 in the hepatoma cells, CXCL2 plays a role in promoting the migration of hepatoma cells, the promoting effect of invasion and the inhibition effect on its adhesion ability. It shows that CXCL2 is combined with its receptor CXCR2. (5) after CXCL2 overexpression, the detection of HSP27, PRAS40 in hepatoma cells through the signal pathway chip is found. The phosphorylation level of bad, Chk1, Ik B alpha (Ser32/36) was significantly up-regulated, and Ik B a (Total) also increased obviously. The results of Western blot confirmed that the phosphorylation level of p-Ik alpha in hepatoma cells was significantly higher after the overexpression CXCL2, indicating that the pathway was activated in the hepatocellular carcinoma cells, which were overexpressed. (6) further through the specific inhibitors 82 blocking the NF-k B pathway of hepatoma cells, and finding that the ability of CXCL2 to promote the migration and invasion of hepatoma cells weakened. The results showed that the CXCL2 of tumor related macrophage derived mainly through the activation of NF-k B signaling pathway to promote the migration and invasion of hepatoma cells. Conclusion 1. in vitro induction to obtain the typical phenotypic characteristics of the difference. Activated state macrophages M1 and M2, and M2 conditioned medium can promote the proliferation, migration and invasion of hepatoma cells, and EMT.2. successfully applied low melting point agarose to establish a three-dimensional co culture system of hepatoma cells and M2 type tumor related macrophages, and established different three-dimensional erect by quantitative proteomics technology of I TRAQ markers. The secretory protein expression profiles in the body culture system and 159 differentially secreted protein.3.CXCL2 are identified in the co culture system as a significant increase in the co culture system, which can promote the migration, invasiveness and inhibition of the adhesion of hepatoma cells, and its role is to combine with the CXCR2 receptor expressed in hepatoma cells. Activation of the NF-k B signal pathway is performed.
【学位授予单位】:广西医科大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R735.7
【相似文献】
相关期刊论文 前10条
1 吴孟超;;肝癌外科治疗的近期进展[J];中国普外基础与临床杂志;2006年02期
2 张志敏;;肝癌会遗传吗?[J];肝博士;2006年03期
3 徐连根;周晶;雷伟;沈志祥;;瘦素及其受体在肝癌组织中的表达及意义[J];胃肠病学和肝病学杂志;2006年05期
4 魏丽珍;李胜棉;张楠;温登瑰;周烨;王士杰;;688例肝癌患者发病特点及诊疗状况分析[J];肝脏;2010年02期
5 ;我国科研人员发现促进肝癌生长和转移的相关基因[J];临床荟萃;2010年10期
6 吴生;;盘点诱发肝癌的7大元凶[J];肝博士;2012年01期
7 邓庆华;一家四例肝癌报道[J];中国厂矿医学;1995年06期
8 王定珠;;觥筹交错 过度疲劳 肝癌乘机而入[J];健康博览;2005年11期
9 笑山,吴蓉蓉;喝咖啡可以减少肝癌发生率[J];健康之路;2005年04期
10 ;远离肝癌 预防在先[J];农民文摘;2006年02期
相关会议论文 前10条
1 俞顺章;穆丽娜;;饮水中藻类毒素与肝癌关系和控制的研究(摘要)[A];全国肿瘤流行病学和肿瘤病因学学术会议论文集[C];2007年
2 杨秉辉;;肝癌预防的新话题-非酒精性脂肪性肝病与肝癌[A];第十二届全国肝癌学术会议论文汇编[C];2009年
3 丁光伟;杨玉秀;徐秋霞;徐存拴;;肝癌多基因表达异常初步研究[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
4 吴孟超;;肝癌外科治疗的近期进展[A];第三届全国重型肝病及人工肝血液净化学术年会论文集(上册)[C];2007年
5 刘耕陶;孙华北;方亚南;;肝癌发生的化学预防[A];第十次中国生物物理学术大会论文摘要集[C];2006年
6 阮秀花;田葱;张效本;张喜梅;;肝癌患者乙型肝炎病毒感染血清流行病学分析[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
7 阮秀花;田葱;张效本;张喜梅;;肝癌患者乙型肝炎病毒感染血清流行病学分析[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
8 吕岩;韩学锋;;肝癌患者需求的评估[A];中华医学会医学工程学分会第八次学术年会暨《医疗设备信息》创刊20周年庆祝会论文集[C];2006年
9 孙华;魏怀玲;刘耕陶;;双环醇对化学毒物促发肝癌的防治作用及作用机制研究[A];2009医学前沿论坛暨第十一届全国肿瘤药理与化疗学术会议论文集[C];2009年
10 谢静媛;戴炜;涂爱民;赵文高;符花;胡应龙;;深圳地区53例肝癌发生的相关因素探讨[A];全国第2届中西医结合传染病学术会议暨国家中医药管理局第1届传染病协作组会议论文汇编[C];2008年
相关重要报纸文章 前10条
1 湖北宜昌 胡献国;吸烟与肝癌[N];上海中医药报;2013年
2 四川成都 孙清廉;远离肝癌 谨防四大危险因素[N];上海中医药报;2013年
3 特约撰稿 北京朝阳医院京西院区肝胆外科主任 孙文兵;警惕肝癌的过度治疗[N];医药导报;2007年
4 健康时报特约记者 孙理;三招不得肝癌[N];健康时报;2008年
5 叶建平;专家提醒肝癌患者保护生命 重在“三早”防治[N];中国中医药报;2008年
6 通讯员 韦夏 本报记者 邓宏鹰 钟少鸿;不良饮食习惯易诱发肝癌[N];中国食品报;2009年
7 记者 顾泳;我国肝癌患者占全球55%[N];解放日报;2010年
8 解放军302医院 刘士敬;四成肝癌酒精泡出来的[N];健康时报;2010年
9 记者 颜维琦 曹继军;我科学家揭示肝癌发生早期分子机制[N];光明日报;2012年
10 记者 胡德荣;肝癌发生早期阶段分子机制被揭示[N];健康报;2012年
相关博士学位论文 前10条
1 陈放;TOPK蛋白和肝癌发生以及相关调控机制的研究[D];复旦大学;2011年
2 张怡安;中枢神经特异性RNA结合蛋白NOVA1在肝癌中的表达及其促进肿瘤发展的潜在分子机制探究[D];复旦大学;2014年
3 殷杰;E3泛素连接酶Prp19对肝癌侵袭的影响及其机制研究[D];复旦大学;2014年
4 周宇红;分化抑制因子ID1在调控化疗诱导的肝癌细胞“干性”改变中的作用研究[D];复旦大学;2014年
5 王盛;FOXA1基因变异和调控异常促,
本文编号:1819839
本文链接:https://www.wllwen.com/yixuelunwen/zlx/1819839.html